AI assistant
BIODESIX INC — Director's Dealing 2025
May 22, 2025
34472_dirs_2025-05-22_850f54a5-1642-4722-8888-542059f1bb43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-05-20
Reporting Person: Strobeck Matthew (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | Restricted Stock Units | $ | A | 80525 | Acquired | Common Stock (80525) | Direct | |
| 2025-05-20 | Stock Options (Right to Buy) | $0.2708 | A | 42010 | Acquired | 2035-05-19 | Common Stock (42010) | Direct |
Footnotes
F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
F2: These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F3: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
F4: This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer.